A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy
M. Isabel Colado, Esther O’shea, R Granados, Aditya Misra, Tracey K. Murray, A. R. Green
British Journal of Pharmacology June 1, 1997 DOI: 10.1038/sj.bjp.0701201 via OpenAlex
Summary
AI-generated from the abstractHigh doses of MDMA (ecstasy) given to pregnant rats on days 14–17 of gestation caused a marked hyperthermic response in the mothers, reduced their body weight, and decreased litter size by about 20%. In the mothers' brains, serotonin (5-HT) and its metabolite 5-HIAA fell by over 65% in the hippocampus and striatum and by 40% in the cortex one week after birth. However, the brains of the newborn pups showed no such decreases. MDMA also increased lipid peroxidation (TBARS) in the cortex of adult rats but not in 7–10 day old neonates.
Study at a glance
| Characteristics | Animal experiment Peer reviewed |
|---|---|
| Population | Pregnant rats and their neonates |
| Intervention | MDMA |
| Dose | 20 mg/kg twice daily on days 14–17 of gestation; 40 mg/kg single dose for adult and neonatal lipid peroxidation experiments |
| Duration | Days 14–17 of gestation for prenatal exposure; 3 and 6 hours post-injection for lipid peroxidation; 1 week after parturition for maternal brain analysis |
| Topics | MDMA Serotonin |
| Keywords | Endocrinology Striatum |
| Citations | 176 |
| Key finding | MDMA administered to pregnant rats during late gestation damaged serotonin nerve terminals in the mothers' brains but not in the brains of their newborn pups. |
Abstract
It is well established that 3,4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy’) is neurotoxic and produces long term degeneration of cerebral 5‐hydroxytryptamine (5‐HT) nerve terminals in many species. Since MDMA is used extensively as a recreational drug by young people, it is being ingested by many women of child bearing age. We have therefore examined the effect of administering high doses of MDMA to rats during pregnancy on the cerebral content of both the dams and the neonates. MDMA (20 mg kg −1 , s.c.) was injected twice daily on days 14–17 of the gestation period. The initial dose produced a marked hyperthermic response in the dam which was progressively attenuated in both peak height and area under the curve following further doses of the drug. The body weight of the dams decreased during the period of treatment. There was a modest decrease in litter size (−20%) of the MDMA‐treated dams. The concentration of 5‐HT and its metabolite 5‐HIAA was decreased by over 65% in the hippocampus and striatum and 40% in the cortex of the dams 1 week after parturition. In contrast, the content of 5‐HT and 5‐HIAA in the dorsal telencephalon of the pups of the MDMA‐treated dams was the same as that seen in tissue from pups born to control animals. Administration of MDMA (40 mg kg −1 , s.c.) to adult rats increased thiobarbituric acid reacting substances (TBARS) in cortical tissue 3 h and 6 h later, indicating increased lipid peroxidation. No increase in TBARS was seen in the cortical tissue of 7–10 day neonates injected with this dose of MDMA 3 h or 6 h earlier. The data suggest that exposure to MDMA in utero during the maturation phase does not produce damage to 5‐HT nerve terminals in the foetal rat brain, in contrast to the damage seen in the brains of the mothers. This may be due to MDMA being metabolized to free radical producing entities in the adult brain but not in the immature brain or, alternatively, to more effective or more active free radical scavenging mechanisms being present in the immature brain. British Journal of Pharmacology (1997) 121 , 827–833; doi: 10.1038/sj.bjp.0701201